related documents
- DENOSUMAB (DMAB) TREATMENT FOR 6 YEARS MAINTAINS LOW FRACTURE INCIDENCE IN WOMEN >= 75 YEARS WITH POSTMENOPAUSAL OSTEOPOROSIS (PMO) Conferences
- DENOSUMAB REDUCED OSTEOPOROTIC FRACTURES IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS WITH PRIOR FRACTURE: RESULTS FROM FREEDOM Conferences
- EFFECT OF TERIPARATIDE ON FRACTURE HEALING IN PATIENTS WITH NONDISPLACED INCOMPLETE ATYPICAL FEMUR FRACTURES Conferences
- EFFICACY OF INPATIENT REHABILITATION AFTER OSTEOPOROTIC HIP FRACTURES ON FEMALE ABOVE 75 WITH NEUROLOGICAL IMPAIRMENT Conferences
- FUNCTIONAL RECOVERY AFTER OSTEOPOROTIC HIP FRACTURES IN FEMALE POPULATION ABOVE 75 REGARDING MUSCULOSKELETAL COMORBIDITY Conferences
- HOW PRIMARY CARE PHYSICIANS (PCPS) ASSESS POSTMENOPAUSAL WOMEN FOLLOWING EDUCATION ON THE 2010 OSTEOPOROSIS CANADA GUIDELINES Conferences
- OSTEOPOROSIS AND OSTEOARTHRITIS: SIMILARITIES AND DIFFERENCES Conferences
- OSTEOPOROSIS AND VERTEBRAL FRACTURES ARE IMPORTANT DETERMINANTS OF CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS Conferences
- VERTEBRAL FRACTURE ASSESSMENT-DETECTED ABDOMINAL AORTIC CALCIFICATION AND CARDIOVASCULAR DISEASE IN RHEUMATOID ARTHRITIS Conferences